Smaller Losses, Substantial Cash and a More Interesting Business
Amwell (NYSE: AMWL) heads into its third-quarter earnings announcement with a proposition worth watching: a technology-enabled healthcare business approaching adjusted operating breakeven, supported by nearly $196 million in cash and equivalents and a…
Oura’s proposed Nasdaq debut under OURA is shaping up as more than another wearable-device listing. It is a high-growth health-intelligence story built around a deceptively simple object: a screenless ring that turns sleep, stress, activity, heart health, metabolic health, and women’s health data into…
Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…
